Results

Total Results: 1,643 records

Showing results for "factor".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
    October 01, 2018 - Interviews with our key partners revealed that the most critical factor in selecting the EPC report … Most notably in this pilot, one external factor that created a “burning platform” for Kaiser Permanente … requisite, developing and investing in a relationship with the health care organization is a critical factor
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-careassociated-infections_research-protocol.pdf
    August 26, 2011 - In the RAND Health report, Shekelle et al. 20 noted that context may be the distinguishing factor … Infection rate and risk factor analysis in an orthopaedic ambulatory surgical center.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
    November 30, 2014 - Evidence-based Practice Center Systematic Review Protocol Project Title: Treatments for Fecal Incontinence I. Background and Objectives for the Systematic Review Fecal incontinence (FI) involves recurrent involuntary loss of fecal material.1,2 FI is defined by the frequency of episodes (such as daily or weekly e…
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
    February 04, 2014 - etiologies have also been established, with human papillomavirus (HPV) infection appearing to be a risk factor
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - Effective Health Care Topic Number(s): 0041 Document Completion Date: 6-2-09 1 Results of Topic Selection Process & Next Steps  Clostridium difficile-associated disease (CDAD) will go forward for refinement as a comparative effectiveness or effectiveness review. The scope of this topic, includi…
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-research-methods_research-protocol.pdf
    February 08, 2017 - unexposed (or treatment and control) groups that are nearly identical on all factors except for the factor … screeners): Fruit & Vegetable Intake Screeners in the Eating at America’s Table Study (EATS) Five-Factor … Diet Quality Index 24-hour dietary recall using common Food frequency questionnaires: Behavioral Risk Factor
  7. Prognostic Tests (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - A key factor to consider is what followup times are important to patients, clinicians, or policymakers … Selective reporting biases in cancer prognostic factor studies. … Selective reporting biases in cancer prognostic factor studies. … Selective reporting biases in cancer prognostic factor studies.
  8. Prognostic Tests (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - A key factor to consider is what followup times are important to patients, clinicians, or policymakers … Selective reporting biases in cancer prognostic factor studies. … Selective reporting biases in cancer prognostic factor studies. … Selective reporting biases in cancer prognostic factor studies.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
    November 27, 2012 - are not currently a significant source of *incident* cases of chronic HCV, this risk factor accounts … We revised the Introduction to state: "Transfusions prior to 1992 are a risk factor for HCV infection … Again the bullets are helpful-is cirrhosis or fibrosis the key factor in making treatment decisions.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
    July 01, 2017 - Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Focus of This Summary This is a summary of a systematic review that evaluated the recent evidence regarding the effects of omega-3 fatty acids (FAs), primaril…
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
    September 02, 2016 - Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Omega-3 Fa…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - or repeated percutaneous exposures to blood, with injection drug use being the strongest risk factor
  13. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
    December 05, 2013 - Arthritis and Nontraumatic Joint Disease AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 01: Arthritis and Nontraumatic Joint Disease Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither…
  14. effectivehealthcare.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
    May 27, 2016 - Avoidable decline in ADLS may be viewed as harm not a potentially contributing factor to an adverse … well-trained) staff supervision of residents with dementia is commonly reported as a major contributing factor … It is not necessarily a potential contributing factor. … the report extensively and this information no longer appears as a safety issue but a potential factor
  15. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - 71 Abstract This chapter provides an overview of considerations for the development of outcome measures for observational comparative effectiveness research (CER) studies, describes implications of the proposed outcomes for study design, and enumerates issues of bias that may arise in incorporating the ascertainme…
  16. S158 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - ORIGINAL ARTICLE Adjustments for Unmeasured Confounders in Pharmacoepidemiologic Database Studies Using External Information Til Stürmer, MD,*† Robert J. Glynn, PhD,*†‡ Kenneth J. Rothman, DrPH,*§¶ Jerry Avorn, MD,* and Sebastian Schneeweiss, MD*� Background: Nonexperimental studies of drug effects in large automa…
  17. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - 83.0% to 90.6%) for patients with a circumferential area of Barrett’s esophagus of 3 cm or more, a factor … Cytosponge testing combined with immunohistochemical 3 staining for the biomarker trefoil factor … Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor
  18. Kravitz_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
    January 01, 2012 - Kravitz_ECCS2012 Slide 1: Media, Messages, and Medication: Strategies  To Reconcile What Patients  Hear, What TheyWant, andWhat They Need FromMedications   Richard  L.  Kravitz,  M.D.,  M.S.P.H. University of California, Davis, Department of…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
    December 01, 2015 - Overall, no distinct pattern emerged to establish a particular factor as a modifier of test performance
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
    January 01, 2014 - The original report also included risk factor studies if the reviewers determined they were of good … One study found that a prior room occupant with CDI is a significant risk factor for CDI acquisition … The effect of room on CDI acquisition remained a significant risk factor (P=0.008) when Kaplan-Meier … The authors concluded that a prior room occupant with CDI is a significant risk factor for CDI acquisition … presumed that preservation of the normal intestinal flora during fidaxomicin treatment is a major factor

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: